Characterization of a novel pyranopyridine inhibitor of the AcrAB efflux pump of Escherichia coli
about
RND-type drug efflux pumps from Gram-negative bacteria: molecular mechanism and inhibitionRecent advances toward a molecular mechanism of efflux pump inhibitionUnderstanding the structural mechanisms of antibiotic resistance sets the platform for new discoveryThe ins and outs of RND efflux pumps in Escherichia coliCurrent Advances in Developing Inhibitors of Bacterial Multidrug Efflux PumpsMolecular mechanism of MBX2319 inhibition of Escherichia coli AcrB multidrug efflux pump and comparison with other inhibitorsStructure-activity relationships of a novel pyranopyridine series of Gram-negative bacterial efflux pump inhibitors.The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.The Influence of Efflux Pump Inhibitors on the Activity of Non-Antibiotic NSAIDS against Gram-Negative Rods.Pentanol and Benzyl Alcohol Attack Bacterial Surface Structures DifferentlyTripartite assembly of RND multidrug efflux pumps.Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It.Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivativesPseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies.Mode of action of the 2-phenylquinoline efflux inhibitor PQQ4R against Escherichia coli.Optimization of a novel series of pyranopyridine RND efflux pump inhibitors.Potential strategies for the eradication of multidrug-resistant Gram-negative bacterial infections.Structural and mechanistic diversity of multidrug transporters.Efflux as a mechanism of antimicrobial drug resistance in clinical relevant microorganisms: the role of efflux inhibitors.New Roads Leading to Old Destinations: Efflux Pumps as Targets to Reverse Multidrug Resistance in Bacteria.Novel Piperazine Arylideneimidazolones Inhibit the AcrAB-TolC Pump in Escherichia coli and Simultaneously Act as Fluorescent Membrane Probes in a Combined Real-Time Influx and Efflux Assay.Inactivation or inhibition of AcrAB-TolC increases resistance of carbapenemase-producing Enterobacteriaceae to carbapenems.Reviving Antibiotics: Efflux Pump Inhibitors That Interact with AcrA, a Membrane Fusion Protein of the AcrAB-TolC Multidrug Efflux Pump.The Impact of Efflux Pump Inhibitors on the Activity of Selected Non-Antibiotic Medicinal Products against Gram-Negative Bacteria.soxRS induces colistin hetero-resistance in Enterobacter asburiae and Enterobacter cloacae by regulating the acrAB-tolC efflux pump.A cell-based infection assay identifies efflux pump modulators that reduce bacterial intracellular load.Identification of a Novel Polyamine Scaffold With Potent Efflux Pump Inhibition Activity Toward Multi-Drug Resistant Bacterial Pathogens.N-lauryltyramine capped copper nanoparticles exhibit a selective colorimetric response towards hazardous mercury(ii) ions and display true anti-biofilm and efflux pump inhibitory effects in E. coliInterplay Between the Phenotype and Genotype, and Efflux Pumps in Drug-Resistant Strains of
P2860
Q26827930-F6E10806-15A6-4E87-A9BB-FE223C7F0CF0Q27004685-55A86711-E501-482B-84B7-B8AFBE7B9BD5Q28083259-ABB7A6E0-9C30-446D-B833-C3A77C1CF522Q28084596-A1B88A8B-2499-4914-B8BA-0B9779AE7292Q33659230-2E21607E-6BEC-4763-8FFE-83179713303FQ34299161-60843D34-C06D-438F-B591-25E461696BC7Q35434831-7BA59750-D076-4D7A-B4BE-1C5CD8B5137AQ35482558-1FF6344A-05CF-4FB6-8485-B15475BD3958Q35895154-7AE0B024-0A82-4BB7-B54B-E9C1F92A0417Q36434122-88A0E19C-3BDF-4E15-BF48-642813FA59D3Q36582301-C67EF72D-F223-406F-8EBB-2346484E2544Q36611416-8E9F9250-3706-432C-9565-1540226B0E0BQ36770441-36F6FBD4-01D4-4F54-8A32-3FAA3A0F8F60Q38599969-D3BF1078-EF2A-40CA-9D36-BB9C519FAD09Q38682599-23AA4971-D2A9-483E-9E47-8A96EC4C2C37Q38846064-10790634-C6DB-4377-81D7-0080A45F7E84Q38847017-94B2F947-4E43-4C4A-BCEF-0E12EB4E81AEQ38912551-657725F6-1287-4E02-83EF-4E4B79659BCBQ39021961-98655B2F-F75F-4C89-B2B4-C8C422FFAF28Q39179301-56149C22-C774-4E9D-BDBA-C6EE9AAA3EC9Q39515144-19133DD2-4467-4106-8703-DC3DAF813ADEQ40766720-3D0ABB62-2B69-4D19-9B1D-B3DE7F2EA6C7Q41358824-A4F6EC49-1E2B-4E96-A289-59B3FEC5FCBBQ46432988-F2365918-C19D-4CD8-BC81-FC478E918F1CQ47578842-EEDD2E19-0708-4732-A197-4FCF9E413BCEQ55386133-A79902EF-F2DA-4C58-8F68-8A6498D89094Q55398494-B49F6669-1F36-496B-B9A5-5BD7D08C6B38Q57377210-299E6860-8FFC-4B97-BE79-B953E3554A79Q57486536-DCA7141D-F476-4090-8893-27018DDCB6CB
P2860
Characterization of a novel pyranopyridine inhibitor of the AcrAB efflux pump of Escherichia coli
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Characterization of a novel py ...... fflux pump of Escherichia coli
@en
type
label
Characterization of a novel py ...... fflux pump of Escherichia coli
@en
prefLabel
Characterization of a novel py ...... fflux pump of Escherichia coli
@en
P2093
P2860
P356
P1476
Characterization of a novel py ...... fflux pump of Escherichia coli
@en
P2093
Chad Houseweart
Hiroshi Nikaido
Hong-Suk Kim
Norton P Peet
Sanjay D'Souza
Son T Nguyen
Steven M Kwasny
Terry L Bowlin
Timothy J Opperman
P2860
P304
P356
10.1128/AAC.01866-13
P407
P50
P577
2013-11-18T00:00:00Z